EWP
TXG icon

Elevation Wealth Partners’s 10x Genomics TXG Stock Holding History

Elevation Wealth Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57K Buy
1,487
+1,143
+332% +$30K 0.02% 274
2026
Q1 		$7.3K Buy
344
+79
+30% +$1.58K ﹤0.01% 597
2025
Q4 		$4.32K Buy
265
+51
+24% +$770 ﹤0.01% 667
2025
Q3 		$2.5K Buy
+214
New +$2.79K ﹤0.01% 604

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Elevation Wealth Partners's TXG Position: Q2 2026 in Review

Elevation Wealth Partners increased its 10x Genomics (TXG) stake by 332% in Q2 2026, buying an estimated $30K and bringing the position to 1,487 shares worth $57K. The position accounts for 0.02% of the portfolio, ranked #274.

Elevation Wealth Partners first reported a position in TXG in Q3 2025 and has held it in 4 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Elevation Wealth Partners held 1,487 shares of 10x Genomics worth $57K as of Q2 2026.
  • Elevation Wealth Partners bought 1,143 10x Genomics shares in Q2 2026, an estimated $30K.
  • 10x Genomics made up 0.02% of Elevation Wealth Partners's portfolio in Q2 2026, its #274 holding.
  • Elevation Wealth Partners first reported a position in 10x Genomics in Q3 2025 and has held it in 4 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.